Transitional Cell Carcinoma research hub

BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer

This study looks at treating high-risk bladder cancer that hasn't spread into the bladder muscle. It combines two existing treatments, BCG and Mitomycin, to see if using them together is more effective at stopping the cancer from coming back.